Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.41) by 21.95 percent. This is a 27.27 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $251.147 thousand which beat the analyst consensus estimate of $125.000 thousand by 100.92 percent. This is a 2.61 percent decrease over sales of $257.884 thousand the same period last year.